Back to top
more

UnitedHealth Group (UNH)

(Real Time Quote from BATS)

$577.64 USD

577.64
1,654,960

-11.50 (-1.95%)

Updated Sep 17, 2024 03:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 28% (181 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

by Zacks Equity Research

Sector ETF report for IYH

Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DIA

Abhinab Dasgupta headshot

Beat the Market Like Zacks: Assertio, Brookfield, UnitedHealth, General Mills in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.

Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?

by Zacks Equity Research

Sector ETF report for XLV

Universal Health (UHS) Cuts Guidance, Falls 6.1%: What's Ahead?

by Zacks Equity Research

Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the second quarter, inducing a decline in revenues and profits.

Patterson Companies (PDCO) Q4 Earnings Beat, Revenues Up Y/Y

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal fourth-quarter 2022 results benefit from strength in the Dental and Animal Health segments.

Humana Inc. (HUM) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Humana (HUM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $508.44 in the latest trading session, marking a +0.55% move from the prior day.

Should You Invest in the Vanguard Health Care ETF (VHT)?

by Zacks Equity Research

Sector ETF report for VHT

Panel Of Zacks Experts headshot

Top Stock Picks for Week of June 27, 2022

by Panel Of Zacks Experts

A Healthcare Provider and Energy Stock Worth Looking Into.

The Zacks Analyst Blog Highlights UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt

by Zacks Equity Research

UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt are part of Zacks top Analyst Blog.

Mark Vickery headshot

Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX), and AstraZeneca PLC (AZN).

Select Medical (SEM), Inova Health Form JV in Northern Virginia

by Zacks Equity Research

The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.

UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Why You Should Retain Humana (HUM) in Your Portfolio Now

by Zacks Equity Research

Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.

UnitedHealth (UNH) Unit Unveils Solution to Provide Better Care

by Zacks Equity Research

UnitedHealth's (UNH) subsidiary Optum introduces a solution that can detect tests that are clinically backed, thereby minimizing unrequired tests and offering enhanced care to health plan members.

UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $489.68 in the latest trading session, marking a +1.95% move from the prior day.

Centene (CNC) Stock Jumps 6%: Will It Continue to Soar?

by Zacks Equity Research

Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK

by Zacks Equity Research

UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.

Encompass Health (EHC) Opens EHR-Backed Hospital in Florida

by Zacks Equity Research

Encompass Health (EHC) takes its U.S. inpatient rehabilitation hospital count to 150 with the opening of a hospital in Florida integrated with the sound EHR system of Oracle Cerner.

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

by Zacks Equity Research

Sector ETF report for PTH

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, UnitedHealth Group (UNH) closed at $464.33, marking a +0.56% move from the previous day.

Humana (HUM) Unveils Transition of Units to CenterWell Brand

by Zacks Equity Research

Humana (HUM) announces the rebranding of its pharmacy divisions to the CenterWell brand, reflecting the rapid expansion initiatives to grow the brand and better serve members.

LabCorp (LH) Rides on Innovations Amid Cost Constraints

by Zacks Equity Research

LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.

Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for PFM